Does Current Scientific and Clinical Evidence Support the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Premature Ejaculation? A Systematic Review and Meta-analysis

Journal of Sexual Medicine

Volumn 9, Issue 9, 2012, Pages 2404-2416

  Asimakopoulos, Anastasios D ^a   Miano, Roberto ^b   Agrò, Enrico Finazzi ^b   Vespasiani, Giuseppe ^b   Spera, Enrico ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Pharmacologic Therapy of Premature Ejaculation; Phosphodiesterase Type 5 Inhibitors; Premature Ejaculation; Sildenafil; Tadalafil; Vardenafil

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; NITRIC OXIDE; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SERTRALINE; SILDENAFIL; TADALAFIL; VARDENAFIL;

ANALGESIC ACTIVITY; ARTICLE; BEHAVIOR THERAPY; CLINICAL STUDY; DRUG EFFECT; DRUG EFFICACY; EJACULATION; ERECTILE DYSFUNCTION; EVIDENCE BASED PRACTICE; HUMAN; MEDLINE; META ANALYSIS; MUSCLE RELAXATION; PREMATURE EJACULATION; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; SEMINAL VESICLE; SYMPATHETIC FUNCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84865711264     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02628.x     Document Type: Article

References (66)

1. McMahon CG, Althof SE, Waldinger MD, Porst H, Dean J, Sharlip ID, Adaikan PG, Becher E, Broderick GA, Buvat J, Dabees K, Giraldi A, Giuliano F, Hellstrom WJ, Incrocci L, Laan E, Meuleman E, Perelman MA, Rosen RC, Rowland DL, Segraves R. An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 2008;5:1590-606.
2. McMahon CG. The DSM-IV-TR definition of premature ejaculation and its impact upon the results of epidemiological studies. Eur Urol 2008;53:887-9.
3. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur Urol 2010;57:804-14.
4. Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001;13:41-5.
5. Salonia A, Maga T, Colombo R, Scattoni V, Briganti A, Cestari A, Guazzoni G, Rigatti P, Montorsi F. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002;168:2486-9.
6. Chen J, Mabjeesh NJ, Matzkin H, Greenstein A. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 2003;61:197-200.
7. McMahon CG, Stuckey BG, Andersen M, Purvis K, Koppiker N, Haughie S, Boolell M. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med 2005;2:368-75.
8. Atan A, Basar MM, Tuncel A, Ferhat M, Agras K, Tekdogan U. Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation. Urology 2006;67:388-91.
9. Aversa A, Pili M, Francomano D, Bruzziches R, Spera E, La Pera G, Spera G. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int J Impot Res 2009;21:221-7.
10. Tang W, Ma L, Zhao L, Liu Y, Chen Z. Clinical efficacy of Viagra with behavior therapy against premature ejaculation. Zhonghua Nan Ke Xue 2004;10:366-7, 370, Chinese.
11. Mathers MJ, Klotz T, Roth S, Lümmen G, Sommer F. Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: A randomised, prospective and crossover study. Andrologia 2009;41:169-75.
12. Mattos RM, Marmo Lucon A, Srougi M. Tadalafil and fluoxetine in premature ejaculation: Prospective, randomized, double-blind, placebo-controlled study. Urol Int 2008;80:162-5.
13. Wang WF, Wang Y, Minhas S, Ralph DJ. Can sildenafil treat primary premature ejaculation? A prospective clinical study. Int J Urol 2007;14:331-5.
14. Hosseini MM, Yarmohammadi H. Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation. Urol Int 2007;79:28-32.
15. Zhang XS, Wang YX, Huang XY, Leng J, Li Z, Han YF. Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation. Zhonghua Nan Ke Xue 2005;11:520-2, 525. [Article in Chinese].
16. Gökçe A, Demirtas A, Halis F, Ekmekcioglu O. In vitro measurement of ejaculation latency time (ELT) and the effects of vardenafil on ELT on lifelong premature ejaculators: Placebo-controlled, double-blind, cross-over laboratory setting. Int Urol Nephrol 2010;42:881-7.
17. Gökçe A, Halis F, Demirtas A, Ekmekcioglu O. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: A double-blind laboratory setting study. BJU Int 2010;107:1274-7.
18. Chen J, Keren-Paz G, Bar-Yosef Y, Matzkin H. The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: A critical analysis of basic science and clinical data. Eur Urol 2007;52:1331-9.
19. Wang WF, Minhas S, Ralph DJ. Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation. Int J Androl 2006;29:503-9.
20. Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP binding, cGMP-specific 30, 50-cyclic nucleotide phosphodiesterase. Gene 1998;216:139-47.
21. Schultheiss D, Müller SV, Nager W, Stief CG, Schlote N, Jonas U, Asvestis C, Johannes S, Münte TF. Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: A study with event-related brain potentials. World J Urol 2001;19:46-50.
22. Sato Y, Horita H, Kurohata T, Adachi H, Tsukamoto T. Effect of the nitric oxide level in the medial preoptic area on male copulatory behavior in rats. Am J Physiol 1998;274:R243-7.
23. Castellano M, Rizzoni D, Beschi M, Muiesan ML, Porteri E, Bettoni G, Salvetti M, Cinelli A, Zulli R, Agabiti-Rosei E. Relationship between sympathetic nervous system activity, baroreflex and cardiovascular effects after acute nitric oxide synthesis inhibition in humans. J Hypertens 1995;13:1153-61.
24. Krukoff TL. Central regulation of autonomic function: No brakes? Clin Exp Pharmacol Physiol 1998;25:474-8.
25. Sato Y, Zhao W, Christ GJ. Central modulation of the NO/cGMP pathway affects the MPOA-induced intracavernous pressure response. Am J Physiol Regul Integr Comp Physiol 2001;281:R269-78.
26. Pfaus JG. Neurobiology of sexual behavior. Curr Opin Neurobiol 1999;9:751-8.
27. Hull EM, Lumley LA, Matuszewich L, Dominguez J, Moses J, Lorrain DS. The roles of nitric oxide in sexual function of male rats. Neuropharmacology 1994;33:1499-504.
28. Prickaerts J, van Staveren WC, Sik A, Markerink-van Ittersum M, Niewöhner U, van der Staay FJ, Blokland A, de Vente J. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 2002;113:351-61.
29. Jen PY, Dixon JS, Gosling JA. Co-localization of nitric oxide synthase, neuropeptides and tyrosine hydroxylase in nerves supplying the human post-natal vas deferens and seminal vesicle. Br J Urol 1997;80:291-9.
30. Dixon JS, Jen PY. Development of nerves containing nitric oxide synthase in the human male urogenital organs. Br J Urol 1995;76:719-25.
31. Hedlund P, Ekstrom P, Larsson B, Alm P, Andersson KE. Heme oxygenase and NO-synthase in the human prostate-Relation to adrenergic, cholinergic and peptide-containing nerves. J Auton Nerv Syst 1997;63:115-26.
32. Kaminski HJ, Andrade FH. Nitric oxide: Biologic effects on muscle and role in muscle diseases. Neuromuscul Disord 2001;11:517-24.
33. Uckert S, Bazrafshan S, Scheller F, Mayer ME, Jonas U, Stief CG. Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors. Urology 2007;70:185-9.
34. Bialy M, Beck J, Abramczyk P, Trzebski A, Przybylski J. Sexual behavior in male rats after nitric oxide synthesis inhibition. Physiol Behav 1996;60:139-43.
35. Kato K, Furuya K, Tsutsui I, Ozaki T, Yamagishi S. Cyclic AMP-mediated inhibition of noradrenaline-induced contraction and Ca2+ influx in guinea-pig vas deferens. Exp Physiol 2000;85:387-98.
36. Bultmann R, Klebroff W, Starke K. Nucleotide-evoked relaxation of rat vas deferens: Possible mechanisms. Eur J Pharmacol 2002;436:135-43.
37. Kriegsfeld LJ, Demas GE, Huang PL, Burnett AL, Nelson RJ. Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-). Physiol Behav 1999;67:561-6.
38. Mancina R, Filippi S, Marini M. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Mol Hum Reprod 2005;11:107-15.
39. Djoseland O, Gordeladze JO, Hoglo S, Halse JI, Haugen HN. Evidence for androgen-dependent phosphodiesterase activity in rat seminal vesicle and epididymis. Int J Androl 1980;3:363-6.
40. Yanaka N, Kotera J, Ohtsuka A, Akatsuka H, Imai Y, Michibata H, Fujishige K, Kawai E, Takebayashi S, Okumura K, Omori K. Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene. Eur J Biochem 1998;255:391-9.
41. Uckert S, Oelke M, Stief CG, Andersson K-E, Jonas U, Hedlund P. Immunohistochemical distribution of cAMP and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate. Eur Urol 2006;49:740-5.
42. Frith D, Gibson A. Sildenafil citrate on nitrergic transmission in anococcygeus muscles from the urogenital system of male and female mice. Eur J Pharmacol 2000;400:305-12.
43. Takeda M, Tang R, Shapiro E, Burnett AL, Lepor H. Effects of nitric oxide on human and canine prostates. Urology 1995;45:440-6.
44. Medina P, Segarra G, Torondel B, Chuan P, Domenech C, Vila JM, Lluch S. Inhibition of neuroeffector transmission in human vas deferens by sildenafil. Br J Pharmacol 2000;131:871-4.
45. Uckert S, Bazrafshan S, Sonnenberg JE, Kuczyk MA. Effects of phosphodiesterase inhibitors on the contractile responses of isolated human seminal vesicle tissue to adrenergic stimulation. J Sex Med 2009;6:408-14.
46. Vignozzi L, Filippi S, Morelli A, Luconi M, Jannini E, Forti G, Maggi M. Regulation of epididymal contractility during semen emission, the first part of the ejaculatory process: A role for estrogen. J Sex Med 2008;5:2010-6. Review. Erratum in: J Sex Med. 2008 Oct;5(10):2480.
47. Aversa A, Caprio M, Antelmi A, Armani A, Brama M, Greco EA, Francomano D, Calanchini M, Spera G, Luigi LD, Rosano GM, Lenzi A, Migliaccio S, Fabbri A. Exposure to phosphodiesterase type 5 inhibitors stimulates aromatase expression in human adipocytes in vitro. J Sex Med 2011;8:696-704.
48. Jain NK, Patil CS, Singh A, Kulkarni SK. Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res 2001;909:170-8.
49. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. 2011. The Cochrane Collaboration. Available at: http://www.cochrane-handbook.org (accessed July 2011).
50. Abdel-Hamid IA. Phosphodiesterase 5 inhibitors in rapid ejaculation: Potential use and possible mechanisms of action. Drugs 2004;64:13-26. Review.
51. Giuliano F, Clement P. Physiology of ejaculation: Emphasis on serotonergic control. Eur Urol 2005;48:408-17.
52. Amelar RD, Hotchkis RS. The split ejaculate: Its use in the management of male infertility. Fertil Steril 1965;16:46-60.
53. Gerstenberg TC, Levin RJ, Wagner G. Erection and ejaculation in man. Assessment of the electromyographic activity of the bulbocavernosus and ischiocavernosus muscles. Br J Urol 1990;65:395-402.
54. Moriyama N, Nasu K, Takeuchi T, Akiyama K, Murata S, Nishimatsu H, Yano J, Tsujimoto G, Kawabe K. Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human vas deferens: Comparison with those of epididymal and pelvic portions. Br J Pharmacol 1997;122:1009-14.
55. Higgins JPT, White IR, Anzures-Cabrera J. Meta-analysis of skewed data: Combining results reported on log transformed or raw scales. Stat Med 2008;27:6072-92.
56. Porst H. An overview of pharmacotherapy in premature ejaculation. J Sex Med 2011;8(suppl 4):335-41.
57. McMahon CG, Porst H. Oral agents for the treatment of premature ejaculation: Review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. J Sex Med 2011;8:2707-25.
58. Sunay D, Sunay M, Aydoǧmuş Y, Baǧbanci S, Arslan H, Karabulut A, Emir L. Acupuncture versus paroxetine for the treatment of premature ejaculation: A randomized, placebo-controlled clinical trial. Eur Urol 2011;59:765-71.
59. De Amicis LA, Goldberg DC, LoPiccolo J, Friedman J, Davies L. Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav 1985;14:467-89.
60. Choi HK, Jung GW, Moon KH, Xin ZC, Choi YD, Lee WH, Rha KH, Choi YJ, Kim DK. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 2000;55:257-61.
61. Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: A systematic review and meta-analysis. Int J Impot Res 2004;16:369-81.
62. Althof SE, Abdo CH, Dean J, Hackett G, McCabe M, McMahon CG, Rosen RC, Sadovsky R, Waldinger M, Becher E, Broderick GA, Buvat J, Goldstein I, El-Meliegy AI, Giuliano F, Hellstrom WJ, Incrocci L, Jannini EA, Park K, Parish S, Porst H, Rowland D, Segraves R, Sharlip I, Simonelli C, Tan HM; International Society for Sexual Medicine. International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 2010;7:2947-69.
63. Waldinger MD. Towards evidence-based drug treatment research on premature ejaculation: A critical evaluation of methodology. Int J Impot Res 2003;15:309-13.
64. Farthing MJG. Ethics of publication. In: Hall GM, ed. How to write a paper. 4th edition. London: Blackwell Publishing, BMJ Books; 2008:123-33.
65. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E; European Association of Urology. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur Urol 2010;57:804-14.
66. Schulz KF, Altman DG, Moher D; For the CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Int J Surg 2011;9:672-7.